Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
featured
Published in Primary Care

Journal Scan / Research · April 29, 2015

Differences in the Efficacy and Safety Among Inhaled Corticosteroids/Long-Acting β2-Agonist Combinations in the Treatment of COPD

Pulmonary Pharmacology & Therapeutics

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

Pulmonary Pharmacology & Therapeutics
Differences in the Efficacy and Safety Among Inhaled Corticosteroids (ICS)/Long-Acting Beta2-Agonists (LABA) Combinations in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): Role of ICS
Pulm Pharmacol Ther 2015 Feb 01;30(xx)44-50, M Latorre, F Novelli, B Vagaggini, F Braido, A Papi, A Sanduzzi, P Santus, N Scichilone, P Paggiaro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated